semaglutide and blood clots Wegovy Lawsuit [2026 Update] Does Wegovy Increase the Risk

Participants included adults who had been using GLP-1 for at least three months

and Wegovy® and is only available to people who meet the criteria for use

If you or someone you care about developed a serious medical condition after taking GLP-1 medications, contact our Wegovy lawyers serving Atlanta about filing a lawsuit.

Not for human or veterinary consumption, medical treatment, or diagnostic application

There was a reduced relative and absolute risk of MACE for semaglutide vs comparators across the entire continuum of CV risk

GLP-1 RAs have been shown to result in increased residual gastric contents (RGCs) in patients undergoing EGDs and poor Boston Bowel Preparation Scores (BBPSs) in those undergoing colonoscopies